Cynosure's next-generation monopolar RF device enters the European market as non-invasive skin tightening demand accelerates.
Cynosure Lutronic has rolled out the XERF monopolar RF platform across Europe, positioning the system as a next-generation alternative to existing RF microneedling and monopolar offerings. Monopolar RF delivers deeper dermal heating than fractional RF and avoids the epidermal injury inherent to ablative modalities, making it attractive for practices seeking downtime-free skin tightening in mature and sensitive skin populations.
The timing reflects rising patient demand for non-invasive body contouring and facial tightening, particularly in European markets where combination protocols (RF + injectables) drive higher per-patient revenue. Cynosure's entry intensifies competition against Thermage (Solta), Inmode's Evolab, and emerging Chinese manufacturers flooding the RF space.
Monopolar RF delivers deeper dermal heating than fractional RF and avoids epidermal injury—critical for downtime-free tightening.
For U.S. practice owners, European device launches often precede FDA 510(k) submissions or PMA pathways. Monitor Cynosure's regulatory filings and clinical data; if XERF gains traction abroad, U.S. adoption and pricing pressure will follow within 12–18 months.
Source: original report ↗
Free alerts Free: recall & rule-change alerts for your practice.
Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.
Free · weekly · unsubscribe anytime. Privacy.
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Inside MedSpa Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.
Get the edge · $20/moJoin the owners who run ahead of the industry. Cancel anytime, one click.
